Previous Close | 0.0550 |
Open | 0.0600 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0550 - 0.0600 |
52 Week Range | 0.0500 - 0.2690 |
Volume | |
Avg. Volume | 56,858 |
Market Cap | 9.439M |
Beta (5Y Monthly) | 0.99 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.1080 |
Earnings Date | Sep 06, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Company Was Previously the Highest-Scoring Applicant During the Permitting Process in Redwood City, CaliforniaVANCOUVER, British Columbia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva,” or the “Company”), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today that the Company has started construction on their upcoming Redwoo
Company Reports Successful Medicinal Chemistry Effort to Scale Up Small Molecule Isolated from Cannabis Plant to Support Preclinical and Non-Clinical StudiesVANCOUVER, British Columbia, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva,” or the “Company”), a life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, today announced the successful scal
New Branded Cannabis Product Line Diversifies Company Product Offerings; Compliments Pharmaceutical ResearchVANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life,” “Juva” or the “Company”), a life science company with pharmaceutical research and development and consumer-facing operations in cannabis production and distribution, announced today the launch of the Company’s new product line, Flōs, a branded line of flo